Difference between revisions of "Team:Paris Bettencourt"
Antoine Lev (Talk | contribs) |
|||
| (17 intermediate revisions by 3 users not shown) | |||
| Line 14: | Line 14: | ||
<div class='textbody'> | <div class='textbody'> | ||
| − | <p>StarCores are | + | <p><b>StarCores</b> are these novel, biologically-synhesized, star-shaped Antimicrobial Peptide (AMP). Like antibiotics, AMPs can be used to kill harmful bacteria. Since AMPs attack bacteria differently than conventional antibiotics, <b>the resistance evolution occurs at a much slower rate.</b></br> |
| − | <p>We designed StarCores in response to the specific needs of veterinarians, farmers, and policymakers in France. Our goal was to provide a specific solution for killing Gram-negative bacteria on pig farms. Over the summer, we successfully designed, produced, tested and optimized a novel class of bacteria-killing peptides with high activity and reduced toxicity.</br> | + | <p>We designed StarCores in response to the specific needs of veterinarians, farmers, and policymakers in France. Our goal was to provide a specific solution for killing Gram-negative bacteria on pig farms. Over the summer, we successfully designed, produced, tested, and optimized a novel class of bacteria-killing peptides with <b>high activity and reduced toxicity.</b></br> |
| − | <p>The story of our project unfolds sequentially. For the best experience of our wiki, we invite you to read the sections below in order, starting with Integrated | + | <p>The story of our project unfolds sequentially. For the best experience of our wiki, we invite you to read the sections below in order, starting with <b>Integrated Human Practices (Human Practices I)</b>.</p> |
</div> | </div> | ||
| Line 50: | Line 50: | ||
<a href='https://2018.igem.org/Team:Paris_Bettencourt/Production'> | <a href='https://2018.igem.org/Team:Paris_Bettencourt/Production'> | ||
<div class='medium-square-block-content'> | <div class='medium-square-block-content'> | ||
| − | <img src="https://static.igem.org/mediawiki/2018/ | + | <img src="https://static.igem.org/mediawiki/2018/7/71/T--Paris_Bettencourt--Production_FirstPage.png"> |
</div> | </div> | ||
<div>Production</div> | <div>Production</div> | ||
| Line 59: | Line 59: | ||
<a href='https://2018.igem.org/Team:Paris_Bettencourt/Testing'> | <a href='https://2018.igem.org/Team:Paris_Bettencourt/Testing'> | ||
<div class='medium-square-block-content'> | <div class='medium-square-block-content'> | ||
| − | <img src="https://static.igem.org/mediawiki/2018/ | + | <img src="https://static.igem.org/mediawiki/2018/5/5e/T--Paris_Bettencourt--Testing_FirstPage.png"> |
</div> | </div> | ||
<div>Testing</div> | <div>Testing</div> | ||
| Line 68: | Line 68: | ||
<a href='https://2018.igem.org/Team:Paris_Bettencourt/Modeling'> | <a href='https://2018.igem.org/Team:Paris_Bettencourt/Modeling'> | ||
<div class='medium-square-block-content'> | <div class='medium-square-block-content'> | ||
| − | <img src="https://static.igem.org/mediawiki/2018/ | + | <img src="https://static.igem.org/mediawiki/2018/3/3d/T--Paris_Bettencourt--Modeling_FirstPage.png"> |
</div> | </div> | ||
<div>Modeling</div> | <div>Modeling</div> | ||
| Line 77: | Line 77: | ||
<a href='https://2018.igem.org/Team:Paris_Bettencourt/Optimization'> | <a href='https://2018.igem.org/Team:Paris_Bettencourt/Optimization'> | ||
<div class='medium-square-block-content'> | <div class='medium-square-block-content'> | ||
| − | <img src="https://static.igem.org/mediawiki/2018/d/ | + | <img src="https://static.igem.org/mediawiki/2018/d/df/T--Paris_Bettencourt--Optimization_FirstPage.png"> |
</div> | </div> | ||
<div>Optimization</div> | <div>Optimization</div> | ||
| Line 93: | Line 93: | ||
<a href='https://2018.igem.org/Team:Paris_Bettencourt/Public_Engagement'> | <a href='https://2018.igem.org/Team:Paris_Bettencourt/Public_Engagement'> | ||
<div class='large-block-content'> | <div class='large-block-content'> | ||
| − | <img src="https://static.igem.org/mediawiki/2018/ | + | <img src="https://static.igem.org/mediawiki/2018/7/71/T--Paris_Bettencourt--HPII_FirstPage.png"> |
</div> | </div> | ||
<div>Human Practices II (Public Engagement)</div> | <div>Human Practices II (Public Engagement)</div> | ||
| Line 105: | Line 105: | ||
<div class='grid-container'> | <div class='grid-container'> | ||
<div class='small-block'> | <div class='small-block'> | ||
| − | <a href='https://2018.igem.org/Team:Paris_Bettencourt/ | + | <a href='https://2018.igem.org/Team:Paris_Bettencourt/Members'> |
<div class='small-block-content'> | <div class='small-block-content'> | ||
| − | <img src="https://static.igem.org/mediawiki/2018/ | + | <img src="https://static.igem.org/mediawiki/2018/9/97/T--Paris_Bettencourt--Team_FirstPage.png"> |
</div> | </div> | ||
<div>Team</div> | <div>Team</div> | ||
| Line 134: | Line 134: | ||
<a href='https://2018.igem.org/Team:Paris_Bettencourt/Medal_Criteria'> | <a href='https://2018.igem.org/Team:Paris_Bettencourt/Medal_Criteria'> | ||
<div class='small-block-content'> | <div class='small-block-content'> | ||
| − | <img src="https://static.igem.org/mediawiki/2018/ | + | <img src="https://static.igem.org/mediawiki/2018/c/ca/T--Paris_Bettencourt--Medal_FirstPage.png"> |
</div> | </div> | ||
<div>Medal Criteria</div> | <div>Medal Criteria</div> | ||
| Line 144: | Line 144: | ||
</div> | </div> | ||
| + | <br> | ||
| + | <br> | ||
| + | <br> | ||
| + | <div> | ||
| + | <div class='textbody'> | ||
| + | <h3>Giant Jamboree 2018 Results!</h3> | ||
| + | <br> | ||
| + | <img src="https://static.igem.org/mediawiki/2018/c/ca/T--Paris_Bettencourt--Medal_FirstPage.png" style="float:left;width:100px;height:100px;"> | ||
| + | <b>Gold Medal </b><br> | ||
| + | Nominations for <b>Best New Composite Part </b> and <b>Best Software</b><br><b><a href="https://synbiobeta.com/cell-free-expression-platforms-enable-new-possibilities-at-igem-and-beyond/">Synbiobeta wrote an article on us! </b> | ||
| + | </div> | ||
</body> | </body> | ||
Latest revision as of 00:50, 8 December 2018
Protein scaffolds for star-shaped antimicrobial peptides
StarCores are these novel, biologically-synhesized, star-shaped Antimicrobial Peptide (AMP). Like antibiotics, AMPs can be used to kill harmful bacteria. Since AMPs attack bacteria differently than conventional antibiotics, the resistance evolution occurs at a much slower rate.
We designed StarCores in response to the specific needs of veterinarians, farmers, and policymakers in France. Our goal was to provide a specific solution for killing Gram-negative bacteria on pig farms. Over the summer, we successfully designed, produced, tested, and optimized a novel class of bacteria-killing peptides with high activity and reduced toxicity.
The story of our project unfolds sequentially. For the best experience of our wiki, we invite you to read the sections below in order, starting with Integrated Human Practices (Human Practices I).
Giant Jamboree 2018 Results!
Gold Medal Nominations for Best New Composite Part and Best Software
Synbiobeta wrote an article on us!
Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
paris-bettencourt-2018@cri-paris.org
paris-bettencourt-2018@cri-paris.org 
